Director Patient Marketing
ITF Therapeutics
Director Patient Marketing
ITF Therapeutics
Develops and commercializes rare-disease therapies
About This Role:
As the Director of Patient Marketing for Duvyzat at ITF Therapeutics, you will be responsible for developing and implementing strategic initiatives that align with the brand strategy to engage and collaborate with the individuals, caregivers, and families of those living with Duchenne muscular dystrophy, a rare, genetic, neuromuscular disease. You will play a critical role in shaping Duvyzat’s brand perception as well as driving adoption, compliance and persistence for this underserved rare disease community.
This role will be hybrid, so candidates applying must be willing and able to come to our office in Concord, MA on a weekly basis.
What You’ll Do:
Who you Are and Required Skills:
Additional Information:
The base compensation range for this role is: $220,000 - $250,000. Compensation is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Develops and commercializes rare-disease therapies
ITF Therapeutics is a division of Italfarmaco S.p.A. focused on developing and commercializing treatments for rare diseases in the U.S., especially Duchenne Muscular Dystrophy (DMD). The company works on early-stage research and clinical development, partnering with patient advocacy groups and clinical leaders to align programs with patient needs. Its lead program is DUVYZAT (givinostat), a histone deacetylase (HDAC) inhibitor aimed at DMD. Revenue comes from bringing these specialized therapies to market. Compared with competitors, ITF Therapeutics emphasizes collaboration with patient groups and clinicians, a pipeline-focused early-development approach, and a specialty in HDAC inhibitors for rare diseases. The company’s goal is to deliver effective treatments for rare-disease patients by advancing promising therapies through development and into commercialization.
Explore more opportunities at ITF Therapeutics